title: Imatinib for the treatment of refractory, diffuse systemic sclerosis.
authors.forename: P P
authors.initials: PP
authors.lastname: Sfikakis
authors.forename: V G
authors.initials: VG
authors.lastname: Gorgoulis
authors.forename: C G
authors.initials: CG
authors.lastname: Katsiari
authors.forename: K
authors.initials: K
authors.lastname: Evangelou
authors.forename: C
authors.initials: C
authors.lastname: Kostopoulos
authors.forename: C M
authors.initials: CM
authors.lastname: Black
mesh_terms: D000328:Adult; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D045743:Scleroderma, Diffuse / Q000188:drug therapy*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate